US20230149523A1 - Treatment of autoimmunity and transplant rejection through
establishment and/or promotion of tolerogenic processes by fibroblast-mediated …

The disclosure provides means of treating autoimmunity through reprogramming of antigen
presenting cells in an individual in need of treatment through administration of fibroblasts …